Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

William Kurtz

Adult Reconstructive Orthopaedic Surgery Brentwood, TN Medical Doctor

NPI 1982657276 CMS profile 226255

134 Franklin Rd, Brentwood, TN 37027

Open in the dashboard

General payments

$773,618

160 records reported · program years 2019–2025

Research payments

$49,075

Paid to them · 15 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$55,659 paid to institutions, not to them · program years 2020–2022

Through program year 2025, William Kurtz of Brentwood, TN is reported in the CMS Open Payments database as having received $773,618 across 160 general payments and $49,075 in research payments paid to them. Separately, studies naming them as principal investigator received $55,659 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $146,535 12
2024 General $92,539 17
2023 General $64,002 5
2022 General $136,748 15
2021 General $105,173 39
2020 General $103,493 21
2020 Research $17,545 5
2019 General $125,129 51
2019 Research $31,530 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Kurtz
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to William Kurtz were reported at $146,535. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year William Kurtz Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $125,129 $1,416 $292–$9,336 $163
2020 $103,493 $647 $141–$6,474 $114
2021 $105,173 $1,073 $211–$6,497 $132
2022 $136,748 $1,217 $236–$6,299 $149
2023 $64,002 $1,082 $246–$6,818 $160
2024 $92,539 $1,575 $323–$8,944 $164
2025 $146,535 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Conformis, Inc. $525,667 94 payments
  2. restor3d, inc. $238,830 25 payments
  3. Flexion Therapeutics, Inc. $3,868 3 payments
  4. Smith+Nephew, Inc. $3,307 13 payments
  5. Medacta USA, Inc. $899 6 payments
  6. Stryker Corporation $493 6 payments
  7. Zimmer Biomet Holdings, Inc. $217 2 payments
  8. DePuy Synthes Sales Inc. $153 3 payments
  9. Medical Device Business Services, Inc. $46 2 payments
  10. Pacira Pharmaceuticals Incorporated $42 1 payment
  11. Other $97 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $598,164 35 payments
  2. Royalty or License $139,240 4 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $21,375 10 payments
  4. Travel and Lodging $11,231 54 payments
  5. Food and Beverage $3,608 57 payments
Products named General payments · program years 2019–2025
  1. iTotal Identity PS Orthopedic implants $135,028 4 payments
  2. iTotal Hip $119,576 7 payments
  3. CONFORMIS HIP SYSTEM Orthopaedic Implants $99,783 3 payments
  4. iTotal Hip Replacement System $99,783 3 payments
  5. iTotal, Identity, Hip $98,624 5 payments
  6. Hip $98,348 26 payments
  7. iTotal Identity CR $96,396 15 payments
  8. iTotal Identity PS Orthopaedic Implants $88,590 9 payments
  9. iTotal Identity Cruciate Retaining Knee Replacement System $46,175 2 payments
  10. Conformis Hip System Orthopedic implants $35,245 1 payment
  11. Other $120,404 97 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Conformis, Inc. $49,075 15 payments

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

709

Median for Orthopedic Surgery: 203

Drug cost

$4,676

Median for Orthopedic Surgery: $1,433

Branded share of claims

12.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 67 $1,350
Gabapentin Generic 109 $601
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 53 $596
Meloxicam Generic 226 $508
Doxycycline Hyclate Generic 13 $391
Methylprednisolone Generic 50 $360
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 37 $318
Ibuprofen Generic 29 $176
Tramadol Hcl Generic 45 $132
Cyclobenzaprine Hcl Generic 21 $79

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 73 billing codes

Paid by Medicare

$243,961

Of which drugs: $1,133

Medicare patients

602

Average age 73

Services billed

9,866

395 women, 207 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 73%
Ischemic heart disease 25%
Diabetes 24%
Depression 22%
Chronic kidney disease 19%
Cancer 16%
Atrial fibrillation 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 126 7,160 $715
Injection, ketorolac tromethamine, per 15 mg J1885 Office 154 443 $219
Injection, methylprednisolone acetate, 40 mg J1030 Office 44 49 $166

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

175 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record